Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

BACKGROUND: The efficacy of autologous stem-cell transplantation during the first remission in patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate risk or high risk on the International Prognostic Index remains controversial and is untested in the rituximab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stiff, Patrick J., Unger, Joseph M., Cook, James R., Constine, Louis S., Couban, Stephen, Stewart, Douglas A., Shea, Thomas C., Porcu, Pierluigi, Winter, Jane N., Kahl, Brad S., Miller, Thomas P., Tubbs, Raymond R., Marcellus, Deborah, Friedberg, Jonathan W., Barton, Kevin P., Mills, Glenn M., LeBlanc, Michael, Rimsza, Lisa M., Forman, Stephen J., Fisher, Richard I., M.D
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3985418/
https://ncbi.nlm.nih.gov/pubmed/24171516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1301077
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados